These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19168229)

  • 61. Intravenous immunoglobulin therapy for hypocomplementemic urticarial vasculitis associated with systemic lupus erythematosus in a child.
    Yamazaki-Nakashimada MA; Duran-McKinster C; Ramírez-Vargas N; Hernandez-Bautista V
    Pediatr Dermatol; 2009; 26(4):445-7. PubMed ID: 19689522
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cognitive impairment and employment status in systemic lupus erythematosus: a prospective longitudinal study.
    Appenzeller S; Cendes F; Costallat LT
    Arthritis Rheum; 2009 May; 61(5):680-7. PubMed ID: 19405004
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neuropsychiatric systemic lupus erythematosus.
    Isenberg D; Crawley E; Woo P
    Ann Rheum Dis; 1999 Oct; 58(10):658-9. PubMed ID: 10577376
    [No Abstract]   [Full Text] [Related]  

  • 64. Stressful life events and skin diseases: an additional perspective from research on psychosomatic dynamics in systemic lupus erythematosus.
    Schubert C; Geser W; Noisternig B; König P; Rumpold G; Lampe A
    Psychother Psychosom; 2002; 71(2):123-6. PubMed ID: 11844950
    [No Abstract]   [Full Text] [Related]  

  • 65. [Frequency of hematological and immunological manifestations of lupus in Dakar].
    Ndiaye FS; Ndongo S; Fall S; Lèye Y; Dioum A; Ka MM; Moréira-Diop T
    Dakar Med; 2008; 53(3):192-7. PubMed ID: 19626790
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Lupus erythematosus, the unknown, invisible and incurable disease].
    Aries M
    Krankenpfl Soins Infirm; 1994 Jun; 87(6):60-4. PubMed ID: 8015267
    [No Abstract]   [Full Text] [Related]  

  • 67. [Differences of clinical manifestations and pathology between boys and girls with systemic lupus erythematosus].
    Tang XD; Lin RX; Huang LJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Apr; 10(2):236-8. PubMed ID: 18433556
    [No Abstract]   [Full Text] [Related]  

  • 68. Persistent thrombocytosis in systemic lupus erythematosus. Activity, reactivity, or what?
    Sánchez-Guerrero SA; Sánchez-Guerrero J
    J Rheumatol; 2007 Jul; 34(7):1441-2. PubMed ID: 17611959
    [No Abstract]   [Full Text] [Related]  

  • 69. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong.
    Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
    Rheumatology (Oxford); 2009 May; 48(5):564-8. PubMed ID: 19269959
    [TBL] [Abstract][Full Text] [Related]  

  • 71. How to improve morbidity and mortality in systemic lupus erythematosus.
    Urowitz MB; Gladman DD
    Rheumatology (Oxford); 2000 Mar; 39(3):238-44. PubMed ID: 10788530
    [No Abstract]   [Full Text] [Related]  

  • 72. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
    Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB
    Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identity loss due to chronic fingertip ischemia.
    Crispin JC; Fallena M; Kraus A
    J Rheumatol; 2004 Jun; 31(6):1222-4. PubMed ID: 15170940
    [No Abstract]   [Full Text] [Related]  

  • 74. [Secondary amyloidosis and systemic lupus erythematosus].
    Monteiro P; Abreu P; Salvador MJ; Malcata A
    Acta Reumatol Port; 2009; 34(2B):400-4. PubMed ID: 19727051
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Factitious simulation of systemic lupus erythematosus.
    Apfelbaum JD; Williams HJ
    West J Med; 1994 Mar; 160(3):259-61. PubMed ID: 8191767
    [No Abstract]   [Full Text] [Related]  

  • 76. Acute acalculous cholecystitis in juvenile systemic lupus erythematosus.
    Mendonça JA; Marques-Neto JF; Prando P; Appenzeller S
    Lupus; 2009 May; 18(6):561-3. PubMed ID: 19395459
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Visceral lupus erythematosus in men and animals. II].
    Hijmans W
    Ned Tijdschr Geneeskd; 1967 Sep; 111(39):1709-11. PubMed ID: 6078655
    [No Abstract]   [Full Text] [Related]  

  • 78. Assessment of disease activity and quality of life in systemic lupus erythematosus - New aspects.
    Yee CS; McElhone K; Teh LS; Gordon C
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):457-67. PubMed ID: 19591777
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cognitive function in systemic lupus erythematosus: results of a 5-year prospective study.
    Hanly JG; Cassell K; Fisk JD
    Arthritis Rheum; 1997 Aug; 40(8):1542-3. PubMed ID: 9259438
    [No Abstract]   [Full Text] [Related]  

  • 80. Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus.
    Haddouk S; Marzouk S; Jallouli M; Fourati H; Frigui M; Hmida YB; Koubaa F; Sellami W; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
    Rheumatology (Oxford); 2009 Aug; 48(8):953-7. PubMed ID: 19502474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.